Clinical Trial: A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Influenza, Human
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in
Brief Summary:
The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a single shot is safe and can help produce antibodies to defend the body against both SARS-CoV-2 (the virus that causes COVID-19) and influenza.Participants enrolled in this trial will be healthy adults, 50 years of age or older.
Read more